Krishnarajah Nirantharakumar
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Polycystic Ovary Syndrome | 1 | 2021 | 151 | 0.74 | Why? |
| Thyrotropin | 1 | 2019 | 262 | 0.69 | Why? |
| Calcium Channel Blockers | 1 | 2021 | 367 | 0.68 | Why? |
| Thyroxine | 1 | 2019 | 250 | 0.68 | Why? |
| Hypothyroidism | 1 | 2019 | 239 | 0.66 | Why? |
| Birth Weight | 1 | 2018 | 250 | 0.63 | Why? |
| Fractures, Bone | 2 | 2019 | 487 | 0.63 | Why? |
| Metformin | 1 | 2021 | 640 | 0.53 | Why? |
| Diabetes, Gestational | 1 | 2019 | 426 | 0.52 | Why? |
| Thyroid Neoplasms | 1 | 2019 | 422 | 0.52 | Why? |
| Hypoglycemia | 1 | 2017 | 406 | 0.48 | Why? |
| Dyslipidemias | 1 | 2018 | 791 | 0.44 | Why? |
| Disease Susceptibility | 3 | 2021 | 4002 | 0.44 | Why? |
| Pregnancy Complications | 2 | 2019 | 1388 | 0.41 | Why? |
| Non-alcoholic Fatty Liver Disease | 1 | 2019 | 907 | 0.40 | Why? |
| Propensity Score | 4 | 2021 | 2690 | 0.38 | Why? |
| Hypoglycemic Agents | 2 | 2021 | 2165 | 0.37 | Why? |
| Antihypertensive Agents | 1 | 2021 | 1962 | 0.36 | Why? |
| Cardiovascular Diseases | 5 | 2021 | 11497 | 0.36 | Why? |
| Diabetes Complications | 1 | 2018 | 2358 | 0.30 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2021 | 3892 | 0.27 | Why? |
| Diabetes Mellitus, Type 2 | 2 | 2021 | 6166 | 0.25 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 5277 | 0.25 | Why? |
| Hypertension | 2 | 2021 | 8895 | 0.24 | Why? |
| Proportional Hazards Models | 4 | 2021 | 6543 | 0.22 | Why? |
| United Kingdom | 8 | 2021 | 18046 | 0.21 | Why? |
| Models, Statistical | 1 | 2018 | 5312 | 0.21 | Why? |
| Mortality | 3 | 2021 | 7132 | 0.20 | Why? |
| Diabetes Mellitus | 2 | 2021 | 8207 | 0.19 | Why? |
| Prediabetic State | 1 | 2021 | 200 | 0.18 | Why? |
| Osteoarthritis | 1 | 2021 | 205 | 0.18 | Why? |
| Obesity, Metabolically Benign | 1 | 2018 | 20 | 0.18 | Why? |
| Body Mass Index | 3 | 2021 | 4306 | 0.18 | Why? |
| Analgesics | 1 | 2021 | 451 | 0.16 | Why? |
| Reference Values | 1 | 2019 | 795 | 0.16 | Why? |
| Testosterone | 1 | 2021 | 596 | 0.15 | Why? |
| Stakeholder Participation | 1 | 2018 | 481 | 0.14 | Why? |
| Intimate Partner Violence | 1 | 2020 | 363 | 0.14 | Why? |
| Thyroid Gland | 1 | 2019 | 516 | 0.14 | Why? |
| Female | 17 | 2021 | 380317 | 0.13 | Why? |
| Diabetes Mellitus, Type 1 | 2 | 2019 | 1969 | 0.13 | Why? |
| Cohort Studies | 4 | 2021 | 36005 | 0.13 | Why? |
| Risk Factors | 8 | 2021 | 71621 | 0.13 | Why? |
| Retrospective Studies | 8 | 2021 | 105322 | 0.13 | Why? |
| Hospitalization | 3 | 2020 | 54280 | 0.12 | Why? |
| Domestic Violence | 1 | 2020 | 522 | 0.12 | Why? |
| Middle Aged | 12 | 2021 | 270681 | 0.12 | Why? |
| Aged | 10 | 2021 | 215776 | 0.12 | Why? |
| Health Services Research | 1 | 2018 | 756 | 0.12 | Why? |
| Adult | 11 | 2021 | 244371 | 0.11 | Why? |
| Kaplan-Meier Estimate | 1 | 2021 | 4260 | 0.11 | Why? |
| Lipids | 1 | 2018 | 1079 | 0.11 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2021 | 1454 | 0.11 | Why? |
| Obesity | 3 | 2021 | 7388 | 0.11 | Why? |
| Area Under Curve | 1 | 2018 | 2564 | 0.10 | Why? |
| Alcoholism | 1 | 2018 | 691 | 0.10 | Why? |
| General Practice | 1 | 2018 | 718 | 0.10 | Why? |
| Male | 13 | 2021 | 367725 | 0.10 | Why? |
| Age Factors | 2 | 2021 | 21039 | 0.09 | Why? |
| Humans | 22 | 2021 | 930598 | 0.09 | Why? |
| Survivors | 1 | 2020 | 2619 | 0.09 | Why? |
| Vitamin D Deficiency | 1 | 2021 | 1782 | 0.08 | Why? |
| Alcohol Drinking | 1 | 2018 | 1663 | 0.08 | Why? |
| Pregnancy | 2 | 2019 | 23879 | 0.08 | Why? |
| Organ Transplantation | 1 | 2021 | 2616 | 0.08 | Why? |
| England | 1 | 2018 | 5116 | 0.08 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.07 | Why? |
| Renin-Angiotensin System | 1 | 2021 | 3661 | 0.07 | Why? |
| Adolescent | 4 | 2021 | 86841 | 0.07 | Why? |
| Electronic Health Records | 1 | 2018 | 3492 | 0.07 | Why? |
| Pregnancy Outcome | 1 | 2018 | 3803 | 0.07 | Why? |
| Young Adult | 4 | 2021 | 93724 | 0.07 | Why? |
| Longitudinal Studies | 1 | 2019 | 9893 | 0.07 | Why? |
| Case-Control Studies | 2 | 2021 | 17671 | 0.07 | Why? |
| Atrial Fibrillation | 1 | 2018 | 2320 | 0.07 | Why? |
| Primary Health Care | 2 | 2021 | 4839 | 0.06 | Why? |
| Quality of Life | 2 | 2021 | 9820 | 0.06 | Why? |
| Incidence | 2 | 2021 | 25622 | 0.06 | Why? |
| Codeine | 1 | 2021 | 32 | 0.06 | Why? |
| Inpatients | 1 | 2017 | 5161 | 0.05 | Why? |
| Sensation Disorders | 1 | 2021 | 103 | 0.05 | Why? |
| Sex Factors | 1 | 2018 | 11014 | 0.05 | Why? |
| Follow-Up Studies | 1 | 2019 | 17020 | 0.05 | Why? |
| Patient Admission | 1 | 2017 | 5250 | 0.05 | Why? |
| Glycated Hemoglobin A | 2 | 2019 | 1316 | 0.05 | Why? |
| Length of Stay | 1 | 2018 | 11042 | 0.05 | Why? |
| Acetaminophen | 1 | 2021 | 326 | 0.04 | Why? |
| Prognosis | 2 | 2020 | 32490 | 0.04 | Why? |
| Anticoagulants | 1 | 2018 | 9563 | 0.04 | Why? |
| Hospital Mortality | 1 | 2020 | 22087 | 0.04 | Why? |
| Cross-Sectional Studies | 3 | 2021 | 53120 | 0.04 | Why? |
| Albuminuria | 1 | 2017 | 164 | 0.04 | Why? |
| Asia, Southeastern | 1 | 2017 | 390 | 0.04 | Why? |
| Depression | 1 | 2020 | 14116 | 0.04 | Why? |
| Lipoproteins, HDL | 1 | 2017 | 154 | 0.04 | Why? |
| Stroke | 1 | 2018 | 8839 | 0.04 | Why? |
| Anxiety | 1 | 2020 | 17311 | 0.03 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.03 | Why? |
| Practice Guidelines as Topic | 1 | 2018 | 15421 | 0.03 | Why? |
| Pain | 1 | 2021 | 1084 | 0.03 | Why? |
| Education | 1 | 2018 | 434 | 0.03 | Why? |
| Respiratory Tract Diseases | 1 | 2021 | 1061 | 0.03 | Why? |
| Drug Combinations | 1 | 2021 | 3852 | 0.03 | Why? |
| Headache | 1 | 2021 | 2257 | 0.03 | Why? |
| Delayed Diagnosis | 1 | 2020 | 1529 | 0.03 | Why? |
| Uncertainty | 1 | 2021 | 1888 | 0.03 | Why? |
| Fatigue | 1 | 2021 | 2479 | 0.03 | Why? |
| Employment | 1 | 2021 | 1754 | 0.02 | Why? |
| Diarrhea | 1 | 2021 | 2743 | 0.02 | Why? |
| Risk | 1 | 2020 | 5288 | 0.02 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.02 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.02 | Why? |
| Cause of Death | 1 | 2021 | 4823 | 0.02 | Why? |
| Survival Rate | 1 | 2020 | 9206 | 0.02 | Why? |
| Qualitative Research | 1 | 2018 | 4337 | 0.02 | Why? |
| Transplant Recipients | 1 | 2021 | 4982 | 0.02 | Why? |
| Blood Glucose | 1 | 2019 | 3642 | 0.02 | Why? |
| Comorbidity | 2 | 2020 | 34796 | 0.02 | Why? |
| Adrenal Cortex Hormones | 1 | 2020 | 6537 | 0.02 | Why? |
| Adaptation, Psychological | 1 | 2021 | 4996 | 0.02 | Why? |
| Referral and Consultation | 1 | 2018 | 4816 | 0.01 | Why? |
| Mental Disorders | 1 | 2021 | 6742 | 0.01 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.01 | Why? |
| Delivery of Health Care | 1 | 2021 | 15909 | 0.01 | Why? |
| Mental Health | 1 | 2021 | 15770 | 0.01 | Why? |
| Risk Assessment | 1 | 2018 | 25439 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
| Treatment Outcome | 1 | 2019 | 51732 | 0.01 | Why? |
| Child | 1 | 2019 | 70012 | 0.01 | Why? |